+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Point-of-Care Glucose Testing Market by Product Type, Test Type, Technology, Portability, End User, Distribution Channel - Global Forecast 2026-2032- Product Image
Point-of-Care Glucose Testing Market by Product Type, Test Type, Technology, Portability, End User, Distribution Channel - Global Forecast 2026-2032- Product Image
Sale

Point-of-Care Glucose Testing Market by Product Type, Test Type, Technology, Portability, End User, Distribution Channel - Global Forecast 2026-2032

  • Report

  • 184 Pages
  • June 2026
  • Region: Global
  • 360iResearch™
  • ID: 5305543
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Point-of-Care Glucose Testing Market is projected to reach USD 4.73 Billion in 2026. It is expected to continue growing at a CAGR of 4.83%, reaching USD 6.29 Billion by 2032.

Point-of-care glucose testing enables rapid blood glucose measurement at the bedside, in clinics, emergency departments, long-term care settings, pharmacies, and homes. Its strategic value is tied to the global diabetes burden: the International Diabetes Federation reported 537 million adults living with diabetes in 2021, with projections of 643 million by 2030 and 783 million by 2045.

For healthcare systems, point-of-care glucose testing supports faster clinical decisions, inpatient glycemic control, hypoglycemia detection, and decentralized chronic disease management. Market relevance is reinforced by accuracy expectations under ISO 15197:2013, CLIA-waived testing pathways in the United States, FDA oversight for glucose monitoring systems, and stronger digital connectivity requirements across hospital glucose meter fleets.

Transformative Shifts in Point-of-Care Glucose Testing

The landscape is shifting from standalone glucose meters toward connected, quality-controlled, and interoperable testing ecosystems. Hospitals increasingly prioritize device integration with electronic health records, operator lockout, barcode patient identification, lot tracking, and centralized data management to reduce transcription errors and strengthen audit readiness.

A second transformation is the movement of glucose monitoring closer to the patient. Retail clinics, community health programs, ambulatory care sites, and home-based care are expanding access, while regulatory scrutiny remains high because insulin dosing and urgent treatment decisions can be made from point-of-care results. This makes analytical accuracy, cybersecurity, supply continuity, quality control compliance, and staff training core purchase criteria.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is adding value around point-of-care glucose testing by improving workflow intelligence rather than replacing validated biochemical measurement. AI-enabled analytics can flag unusual result patterns, detect quality control drift, identify operator training gaps, support exception review, and help clinicians recognize patients at risk of hypo- or hyperglycemia.

The cumulative impact is strongest when glucose meter data, insulin administration records, nutrition data, comorbidities, and electronic health record information are analyzed together. However, industry leaders must validate algorithms, control bias, protect patient data, preserve clinician oversight, and align AI-enabled functions with FDA software guidance, EU IVDR expectations, data protection rules, and hospital governance requirements.

Key Regional Insights Across Global Markets

Asia-Pacific is a high-priority region because China and India have among the world’s largest diabetes populations according to International Diabetes Federation data, while Japan, South Korea, and Australia show strong adoption of regulated digital health infrastructure and quality-focused care pathways. North America remains a benchmark market due to hospital connectivity, CLIA-waived testing, FDA oversight, high awareness of diabetes management, and established reimbursement structures supporting clinical and home-based glucose monitoring.

Europe is shaped by EU IVDR transition requirements, procurement standardization, national diabetes programs, and demand for interoperable medical devices across public health systems. Latin America, led by Brazil and Mexico, is expanding decentralized diabetes care and pharmacy-based access but remains sensitive to affordability, strip availability, and distribution reliability. The Middle East, especially GCC health systems, is investing in diabetes screening, hospital modernization, and premium connected infrastructure, while Africa faces the greatest access gap, making low-cost, rugged, battery-efficient, and training-light glucose testing essential for primary care and outreach settings.

Key Group Insights for Strategic Positioning

ASEAN demand is supported by rising diabetes prevalence, urbanization, expanding primary care networks, and government efforts to improve noncommunicable disease management, with procurement often favoring affordable meters and dependable test strip supply. The GCC prioritizes hospital modernization, diabetes prevention initiatives, population screening, and connected point-of-care platforms suited to high-throughput facilities and digitally enabled care models.

The European Union is driven by IVDR compliance, interoperability, public procurement discipline, and strong clinical governance around in vitro diagnostic performance. BRICS markets combine large patient pools with uneven access, creating demand for scalable distribution, localized manufacturing, and cost-sensitive product tiers. G7 countries lead in quality systems, digital integration, reimbursement maturity, and evidence-based clinical adoption, while NATO members increasingly emphasize resilient supply chains, cybersecurity, standardization, and deployable medical testing capability for civilian and emergency preparedness needs.

Key Country Insights in Point-of-Care Glucose Testing

The United States leads through FDA-regulated hospital glucose systems, CLIA-waived testing settings, extensive diabetes screening infrastructure, and a large diagnosed diabetes population reported by the CDC. Canada emphasizes provincial purchasing, chronic disease management, and equitable access across urban and remote communities. Mexico and Brazil are expanding community-based diabetes care, pharmacy access, and public health initiatives aimed at earlier diagnosis and ongoing monitoring. The United Kingdom, Germany, France, Italy, and Spain are shaped by public reimbursement, procurement discipline, aging populations, structured diabetes care pathways, and EU or UK regulatory oversight for in vitro diagnostics.

Russia remains influenced by import substitution, procurement localization, and supply resilience. China and India are scale markets with major diabetes burdens, rising diagnosis rates, expanding hospital networks, and fast-growing domestic device ecosystems. Japan, Australia, and South Korea prioritize quality, aging-population care, connected medical technology, and strong regulatory compliance, making them attractive for premium point-of-care glucose testing platforms that combine accuracy, traceability, and digital integration.

Actionable Recommendations for Industry Leaders

Industry leaders should compete on clinical reliability, not device price alone. Priority actions include demonstrating ISO 15197-aligned accuracy, supporting hospital-grade connectivity, enabling barcode-based patient and operator identification, simplifying staff training, and offering secure data management that integrates with electronic health records and quality control systems.

Manufacturers should also diversify test strip supply, strengthen cybersecurity controls, localize distribution in high-growth regions, and design tiered portfolios for hospitals, clinics, pharmacies, long-term care facilities, and home users. Commercial teams can improve adoption by publishing real-world workflow evidence, supporting regulatory transitions, training care teams, and partnering with diabetes screening and chronic disease management programs.

Research Methodology

This executive summary is based on secondary research from recognized public health, regulatory, and standards sources, including the International Diabetes Federation, World Health Organization, U.S. Centers for Disease Control and Prevention, U.S. FDA, ISO 15197 guidance, CLIA information, and EU IVDR frameworks.

Insights were synthesized using market triangulation across disease burden, care-setting adoption, regulatory requirements, technology trends, regional healthcare infrastructure, and digital health readiness. Findings emphasize verified drivers, compliance factors, and strategic implications rather than unsupported revenue claims, market sizing, market share, or forecasting.

Conclusion

Point-of-care glucose testing remains a critical component of diabetes management and acute-care decision-making. Adoption is supported by the rising diabetes population, aging demographics, decentralized care models, hospital quality requirements, and the clinical need for rapid, traceable glucose results.

The next phase of competition will center on accuracy, digital interoperability, AI-supported quality intelligence, supply resilience, cybersecurity, and regulatory readiness. Organizations that align affordability with connected clinical-grade performance are best positioned to meet sustainable demand across mature and emerging healthcare systems.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Point-of-Care Glucose Testing Market, by Product Type
7.1. Continuous Glucose Monitoring Devices
7.1.1. Intermittently Scanned
7.1.2. Real Time
7.2. Glucose Meters
7.3. Sensors
7.3.1. Enzymatic
7.3.2. Optical
7.4. Software Apps
7.5. Test Strips
8. Point-of-Care Glucose Testing Market, by Test Type
8.1. Invasive
8.2. Minimally Invasive
8.3. Non Invasive
9. Point-of-Care Glucose Testing Market, by Technology
9.1. Colorimetric
9.2. Electrochemical
9.3. Photometric
10. Point-of-Care Glucose Testing Market, by Portability
10.1. Benchtop
10.2. Portable
11. Point-of-Care Glucose Testing Market, by End User
11.1. Ambulatory Surgical Centers
11.2. Diagnostic Laboratories
11.2.1. Hospital Based Labs
11.2.2. Independent Labs
11.3. Home Care
11.3.1. Assisted Home Care
11.3.2. Self Monitoring
11.4. Hospitals & Clinics
11.4.1. Large Hospitals
11.4.2. Small Clinics
12. Point-of-Care Glucose Testing Market, by Distribution Channel
12.1. Direct Sales
12.2. Hospital Pharmacies
12.3. Online Pharmacies
12.3.1. Manufacturer Websites
12.3.2. Third Party Marketplaces
12.4. Retail Pharmacies
13. Asia-Pacific Point-of-Care Glucose Testing Market
14. Europe Point-of-Care Glucose Testing Market
15. North America Point-of-Care Glucose Testing Market
16. Latin America Point-of-Care Glucose Testing Market
17. Africa Point-of-Care Glucose Testing Market
18. Middle East Point-of-Care Glucose Testing Market
19. NATO Point-of-Care Glucose Testing Market
20. G7 Point-of-Care Glucose Testing Market
21. BRICS Point-of-Care Glucose Testing Market
22. European Union Point-of-Care Glucose Testing Market
23. ASEAN Point-of-Care Glucose Testing Market
24. GCC Point-of-Care Glucose Testing Market
25. China Point-of-Care Glucose Testing Market
26. United States Point-of-Care Glucose Testing Market
27. Japan Point-of-Care Glucose Testing Market
28. India Point-of-Care Glucose Testing Market
29. Germany Point-of-Care Glucose Testing Market
30. United Kingdom Point-of-Care Glucose Testing Market
31. Australia Point-of-Care Glucose Testing Market
32. France Point-of-Care Glucose Testing Market
33. South Korea Point-of-Care Glucose Testing Market
34. Italy Point-of-Care Glucose Testing Market
35. Canada Point-of-Care Glucose Testing Market
36. Russia Point-of-Care Glucose Testing Market
37. Brazil Point-of-Care Glucose Testing Market
38. Mexico Point-of-Care Glucose Testing Market
39. Spain Point-of-Care Glucose Testing Market
40. Competitive Landscape
40.1. Market Concentration Analysis, 2025
40.1.1. Concentration Ratio (CR)
40.1.2. Herfindahl Hirschman Index (HHI)
40.2. Recent Developments & Impact Analysis, 2025
40.3. Product Portfolio Analysis, 2025
40.4. Benchmarking Analysis, 2025
41. Company Profiles
41.1. Abbott Laboratories
41.2. Acon Laboratories, Inc.
41.3. AgaMatrix, Inc.
41.4. ARKRAY, Inc.
41.5. Ascensia Diabetes Care Holdings AG
41.6. B. Braun Melsungen AG
41.7. Becton, Dickinson and Company
41.8. Dexcom, Inc.
41.9. EKF Diagnostics Holdings plc
41.10. F. Hoffmann-La Roche Ltd.
41.11. GlySens, Inc.
41.12. HemoCue AB
41.13. i-SENS, Inc.
41.14. iHealth Labs Inc.
41.15. LifeScan, Inc.
41.16. Medtronic plc
41.17. Nipro Corporation
41.18. Nova Biomedical Corporation
41.19. PTS Diagnostics
41.20. Sanofi S.A.
41.21. Senseonics Holdings, Inc.
41.22. Sinocare Inc.
41.23. Terumo Corporation
41.24. Trividia Health, Inc.
41.25. Ypsomed Holding AG
List of Figures
FIGURE 1. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 6. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 7. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 13. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
FIGURE 14. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 15. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2025 VS 2032 (%)
FIGURE 17. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 19. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 23. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 25. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 27. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. EUROPE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 29. EUROPE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 30. NORTH AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 31. NORTH AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 32. LATIN AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 33. LATIN AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 34. AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 35. AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 36. MIDDLE EAST POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 37. MIDDLE EAST POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 38. NATO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 39. NATO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 40. G7 POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 41. G7 POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 42. BRICS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 43. BRICS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 44. EUROPEAN UNION POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 45. EUROPEAN UNION POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 46. ASEAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 47. ASEAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 48. GCC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 49. GCC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 50. CHINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 51. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 52. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 53. INDIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 54. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 55. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 56. AUSTRALIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 57. FRANCE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 58. SOUTH KOREA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 59. ITALY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 60. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 61. RUSSIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 62. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 63. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 64. SPAIN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SHARE, BY KEY PLAYER, 2025
TABLE 7. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
TABLE 8. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL INTERMITTENTLY SCANNED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL INTERMITTENTLY SCANNED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL INTERMITTENTLY SCANNED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL REAL TIME MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL REAL TIME MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL REAL TIME MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL GLUCOSE METERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL GLUCOSE METERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL GLUCOSE METERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL SENSORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL SENSORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL SENSORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL ENZYMATIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ENZYMATIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ENZYMATIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL OPTICAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL OPTICAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL OPTICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL SOFTWARE APPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL SOFTWARE APPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL SOFTWARE APPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL TEST STRIPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL TEST STRIPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL TEST STRIPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL INVASIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL INVASIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL INVASIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL MINIMALLY INVASIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL MINIMALLY INVASIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL MINIMALLY INVASIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL NON INVASIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL NON INVASIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL NON INVASIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL COLORIMETRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL COLORIMETRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL COLORIMETRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL ELECTROCHEMICAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL ELECTROCHEMICAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL ELECTROCHEMICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL PHOTOMETRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL PHOTOMETRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL PHOTOMETRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL BENCHTOP MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL BENCHTOP MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL BENCHTOP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL PORTABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL PORTABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL PORTABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL HOSPITAL BASED LABS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL HOSPITAL BASED LABS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL HOSPITAL BASED LABS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL INDEPENDENT LABS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL INDEPENDENT LABS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL INDEPENDENT LABS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL HOME CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL HOME CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL HOME CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL ASSISTED HOME CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL ASSISTED HOME CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL ASSISTED HOME CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL SELF MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL SELF MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL SELF MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL LARGE HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL LARGE HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL LARGE HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL SMALL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL SMALL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL SMALL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL DIRECT SALES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL DIRECT SALES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL DIRECT SALES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL HOSPITAL PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL HOSPITAL PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL HOSPITAL PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL MANUFACTURER WEBSITES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL MANUFACTURER WEBSITES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL MANUFACTURER WEBSITES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL THIRD PARTY MARKETPLACES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL THIRD PARTY MARKETPLACES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL THIRD PARTY MARKETPLACES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 114. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 115. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 116. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 117. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 118. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 119. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 120. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 121. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 122. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 123. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 124. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 125. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 126. EUROPE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 127. EUROPE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 128. EUROPE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 129. EUROPE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 130. EUROPE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 131. EUROPE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 132. EUROPE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 133. EUROPE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 134. EUROPE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 135. EUROPE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 136. EUROPE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 137. EUROPE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 138. EUROPE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 139. NORTH AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 140. NORTH AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 141. NORTH AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 142. NORTH AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 143. NORTH AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 144. NORTH AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 145. NORTH AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 146. NORTH AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 147. NORTH AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 148. NORTH AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 149. NORTH AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 150. NORTH AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 151. NORTH AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 152. LATIN AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 153. LATIN AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 154. LATIN AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 155. LATIN AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 156. LATIN AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 157. LATIN AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 158. LATIN AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 159. LATIN AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 160. LATIN AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 161. LATIN AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 162. LATIN AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 163. LATIN AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 164. LATIN AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 165. AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 166. AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 167. AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 168. AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 169. AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 170. AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 171. AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 172. AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 173. AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 174. AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 175. AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 176. AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 177. AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 178. MIDDLE EAST POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 179. MIDDLE EAST POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 180. MIDDLE EAST POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 181. MIDDLE EAST POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 182. MIDDLE EAST POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 183. MIDDLE EAST POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 184. MIDDLE EAST POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 185. MIDDLE EAST POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 186. MIDDLE EAST POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 187. MIDDLE EAST POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 188. MIDDLE EAST POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 189. MIDDLE EAST POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 190. MIDDLE EAST POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 191. NATO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 192. NATO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 193. NATO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 194. NATO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 195. NATO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 196. NATO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 197. NATO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 198. NATO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 199. NATO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 200. NATO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 201. NATO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 202. NATO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 203. NATO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 204. G7 POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 205. G7 POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 206. G7 POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 207. G7 POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 208. G7 POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 209. G7 POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 210. G7 POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 211. G7 POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 212. G7 POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 213. G7 POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 214. G7 POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 215. G7 POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 216. G7 POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 217. BRICS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 218. BRICS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 219. BRICS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 220. BRICS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 221. BRICS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 222. BRICS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 223. BRICS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 224. BRICS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 225. BRICS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 226. BRICS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 227. BRICS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 228. BRICS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 229. BRICS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 230. EUROPEAN UNION POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 231. EUROPEAN UNION POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 232. EUROPEAN UNION POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 233. EUROPEAN UNION POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 234. EUROPEAN UNION POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 235. EUROPEAN UNION POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 236. EUROPEAN UNION POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 237. EUROPEAN UNION POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 238. EUROPEAN UNION POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 239. EUROPEAN UNION POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 240. EUROPEAN UNION POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 241. EUROPEAN UNION POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 242. EUROPEAN UNION POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 243. ASEAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 244. ASEAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 245. ASEAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 246. ASEAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 247. ASEAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 248. ASEAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 249. ASEAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 250. ASEAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 251. ASEAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 252. ASEAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 253. ASEAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 254. ASEAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 255. ASEAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 256. GCC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 257. GCC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 258. GCC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 259. GCC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 260. GCC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 261. GCC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 262. GCC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 263. GCC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 264. GCC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 265. GCC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 266. GCC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 267. GCC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 268. GCC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 269. CHINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 270. CHINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 271. CHINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 272. CHINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 273. CHINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 274. CHINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 275. CHINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 276. CHINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 277. CHINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 278. CHINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 279. CHINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 280. CHINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 281. CHINA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 282. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 283. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 284. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 285. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 286. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 287. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 288. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 289. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 290. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 291. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 292. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 293. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 294. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 295. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 296. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 297. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 298. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 299. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 300. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 301. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 302. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 303. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 304. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 305. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 306. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 307. JAPAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 308. INDIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 309. INDIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 310. INDIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 311. INDIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 312. INDIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 313. INDIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 314. INDIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 315. INDIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 316. INDIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 317. INDIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 318. INDIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 319. INDIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 320. INDIA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 321. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 322. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 323. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 324. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
TABLE 325. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 326. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 327. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 328. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 329. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 330. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 331. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
TABLE 332. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 333. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 334. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 335.

Companies Mentioned

The companies featured in this Point-of-Care Glucose Testing market report include:
  • Abbott Laboratories
  • Acon Laboratories, Inc.
  • AgaMatrix, Inc.
  • ARKRAY, Inc.
  • Ascensia Diabetes Care Holdings AG
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Dexcom, Inc.
  • EKF Diagnostics Holdings plc
  • F. Hoffmann-La Roche Ltd.
  • GlySens, Inc.
  • HemoCue AB
  • i-SENS, Inc.
  • iHealth Labs Inc.
  • LifeScan, Inc.
  • Medtronic plc
  • Nipro Corporation
  • Nova Biomedical Corporation
  • PTS Diagnostics
  • Sanofi S.A.
  • Senseonics Holdings, Inc.
  • Sinocare Inc.
  • Terumo Corporation
  • Trividia Health, Inc.
  • Ypsomed Holding AG

Table Information

Report AttributeDetails
No. of Pages184
PublishedJune 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 4.73 Billion
Forecasted Market Value ( USD ) by 2032 $ 6.29 Billion
Compound Annual Growth Rate4.8%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Point-of-Care Glucose Testing: Market Share, and Growth Analysis by Product Type (Blood Glucose Meters, Continuous Glucose Monitoring Systems), Application, End User, Technology - Product Image

Point-of-Care Glucose Testing: Market Share, and Growth Analysis by Product Type (Blood Glucose Meters, Continuous Glucose Monitoring Systems), Application, End User, Technology

  • Report
  • 150 Pages
  • Global
From
Point-of-Care Glucose Testing Market - Global Strategic Business Report - Product Image

Point-of-Care Glucose Testing Market - Global Strategic Business Report

  • Report
  • 201 Pages
  • Global
From
Point-of-Care Glucose Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Point-of-Care Glucose Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 185 Pages
  • Global
From
Point-of-Care Glucose Testing Market Report 2026 - Product Image

Point-of-Care Glucose Testing Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Network Point-of-Care Glucose Testing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Network Point-of-Care Glucose Testing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 150 Pages
  • Global
From

About the Point of Care Glucose Testing Market

Point of Care Glucose Testing (POCT) is a type of glucose testing that is performed outside of a laboratory setting. It is typically used to monitor glucose levels in patients with diabetes, and is often used in emergency situations. POCT is a convenient and cost-effective way to measure glucose levels, as it does not require a laboratory or specialized equipment. The results are usually available within minutes, allowing for quick and accurate diagnosis and treatment. POCT is also used to monitor glucose levels in pregnant women, as well as to diagnose and monitor other conditions such as hypoglycemia. The POCT market is growing rapidly, driven by the increasing prevalence of diabetes and other chronic conditions, as well as the need for rapid and accurate diagnosis and treatment. The market is also being driven by technological advancements, such as the development of portable and user-friendly devices. Some companies in the POCT market include Abbott, Roche, Siemens, and LifeScan. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.